Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor

By Hu Guodong   Ma Aijing   Dou Xianghua   Zhao Liling   Wang Jihua  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-05 ,pp. : 819-819

MDPI

Access to resources Recommend Favorite

Valproic Acid as a Potential Inhibitor of Plasmodium falciparum Histone Deacetylase 1 (PfHDAC1): An in Silico Approach

By Elbadawi Mohamed A. Abdallah   Awadalla Mohamed Khalid Alhaj   Abdel Hamid Muzamil Mahdi   Mohamed Magdi Awadalla   Awad Talal Ahmed  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-02 ,pp. : 3915-3931

MDPI

Access to resources Recommend Favorite

A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection

By Kishida Yutaka   Imaizumi Naohiko   Tanimura Hirohisa   Kashiwamura Shinichiro   Kashiwagi Toru  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-03 ,pp. : 350-350

MDPI

Access to resources Recommend Favorite

2-O-Acyl-3-O-(1-acyloxyalkyl) Prodrugs of 5,6-Isopropylidene-l-Ascorbic Acid and l-Ascorbic Acid: Antioxidant Activity and Ability to Permeate Silicone Membranes

By Thiele Nikki A.   McGowan Jennifer   Sloan Kenneth B.  

Pharmaceutics, Vol. 8, Iss. 3, 2016-07 ,pp. : 22-22

MDPI

Access to resources Recommend Favorite

Design of Prodrugs to Enhance Colonic Absorption by Increasing Lipophilicity and Blocking Ionization

By Nofsinger Rebecca   Clas Sophie-Dorothee   Sanchez Rosa I.   Walji Abbas   Manser Kimberly   Nissley Becky   Balsells Jaume   Nair Amrithraj   Dang Qun   Bennett David Jonathan   Hafey Michael   Wang Junying   Higgins John   Templeton Allen   Coleman Paul   Grobler Jay   Smith Ronald   Wu Yunhui  

Pharmaceuticals, Vol. 7, Iss. 2, 2014-02 ,pp. : 207-219

MDPI

Access to resources Recommend Favorite